{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:06:41Z","timestamp":1784581601256,"version":"3.55.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.hoc.2026.05.009","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:55:32Z","timestamp":1781726132000},"page":"507-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surgical Considerations for Primary Liver Neoplasms"],"prefix":"10.1016","volume":"40","author":[{"given":"Dillon C.","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee-Chee","family":"Stucky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.hoc.2026.05.009_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70526-z","article-title":"Changes in the epidemiological trends of primary liver cancer in the Asia-Pacific region","volume":"14","author":"Danpanichkul","year":"2024","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.hoc.2026.05.009_bib3","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/cncr.32789","article-title":"Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990-2017","volume":"126","author":"Liu","year":"2020","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.hoc.2026.05.009_bib4","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/cncr.35284","article-title":"The rise of biliary tract cancers and next-generation population registries","volume":"130","author":"Cheung","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2026.05.009_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211051548","article-title":"Trends in incidence and prognostic factors of two subtypes of primary liver cancers: a surveillance, epidemiology, and end results-based population study","volume":"29","author":"Yao","year":"2022","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib6","article-title":"Prognostic factors in patients with intrahepatic cholangiocarcinoma","volume":"14","author":"Chang","year":"2024","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.hoc.2026.05.009_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3349\/ymj.2024.0087","article-title":"Significant improvement in long-term survival after liver resection for hepatocellular carcinoma: evolving outcomes over 20 years","volume":"66","author":"Kim","year":"2025","journal-title":"Yonsei Med J"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.009_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.surg.2023.09.040","article-title":"Combined hepatocellular-cholangiocarcinoma compared to hepatocellular carcinoma and intrahepatic cholangiocarcinoma: different survival, similar recurrence: report of a large study on repurposed databases with propensity score matching","volume":"175","author":"Amory","year":"2024","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.009_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.009_bib10","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.hoc.2026.05.009_bib11","article-title":"Hepatocellular carcinoma: a practical anatomy-based guide for staging and treatment planning, from the AJR special series on critical anatomy","author":"Chiu","year":"2025","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.009_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrac097","article-title":"Impact of post-hepatectomy liver failure on morbidity and short- and long-term survival after major hepatectomy","volume":"6","author":"Baumgartner","year":"2022","journal-title":"BJS Open"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.009_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1477-2574.2010.00181.x","article-title":"Pretreatment assessment of hepatocellular carcinoma: expert consensus statement","volume":"12","author":"Vauthey","year":"2010","journal-title":"HPB (Oxford)"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.009_bib15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: a review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.009_bib16","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/lt.20761","article-title":"Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis","volume":"12","author":"Cucchetti","year":"2006","journal-title":"Liver Transplant"},{"issue":"9","key":"10.1016\/j.hoc.2026.05.009_bib17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jhbp.124","article-title":"Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"21","author":"Choi","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jhep.2015.08.025","article-title":"Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma","volume":"64","author":"Cucchetti","year":"2016","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.009_bib19","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/HEP.0000000000000841","article-title":"Noninvasive liver disease assessment to identify portal hypertension: systematic and narrative reviews supporting the AASLD practice guideline","volume":"81","author":"Rockey","year":"2025","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1477-2574.2012.00594.x","article-title":"Hepatic resection for hepatocellular carcinoma in patients with child-pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?","volume":"15","author":"Santambrogio","year":"2013","journal-title":"HPB (Oxford)"},{"issue":"11","key":"10.1016\/j.hoc.2026.05.009_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107073","article-title":"Is hepatectomy feasible for hepatocellular carcinoma patients with clinically significant portal hypertension and beyond the milan criteria?","volume":"49","author":"Lu","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/SLA.0000000000006185","article-title":"The impact of portal hypertension assessment method on the outcomes of hepatocellular carcinoma resection: a meta-analysis of matched cohort and prospective studies","volume":"280","author":"Aliseda","year":"2024","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.009_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/HEP.0000000000000726","article-title":"Adjuvant and neoadjuvant therapies for hepatocellular carcinoma","volume":"82","author":"Vogel","year":"2025","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.009_bib24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s00268-022-06803-7","article-title":"A conceptual classification of resectability for hepatocellular carcinoma","volume":"47","author":"Yoh","year":"2023","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.009_bib25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2468-1253(24)00434-5","article-title":"Precision surgery for hepatocellular carcinoma","volume":"10","author":"Magyar","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.009_bib26","first-page":"0","article-title":"Oncological resectability criteria for hepatocellular carcinoma in the era of novel systemic therapies: the Japan liver cancer association and Japanese society of hepato-biliary-pancreatic surgery expert consensus statement 2023","volume":"13","author":"Akahoshi","year":"2024","journal-title":"Liver Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.009_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11605-022-05549-w","article-title":"Surgical outcomes for hepatocellular carcinoma in patients with child-pugh class B: a retrospective multicenter study","volume":"27","author":"Tanaka","year":"2023","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2019.08.032","article-title":"Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in child-pugh B cirrhosis","volume":"72","author":"Berardi","year":"2020","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.009_bib29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.hpb.2023.03.002","article-title":"Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion","volume":"25","author":"Kothari","year":"2023","journal-title":"HPB (Oxford)"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.009_bib30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamasurg.2024.1184","article-title":"Liver resection vs nonsurgical treatments for patients with early multinodular hepatocellular carcinoma","volume":"159","author":"Vitale","year":"2024","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.009_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000521665","article-title":"Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial)","volume":"11","author":"Takayama","year":"2022","journal-title":"Liver Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.2471070818","article-title":"Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy","volume":"247","author":"Yamakado","year":"2008","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.hoc.2026.05.009_bib33","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1245\/s10434-025-17776-x","article-title":"Oncological resectability criteria for intrahepatic cholangiocarcinoma: a preoperative framework for multidisciplinary management","volume":"32","author":"Kawashima","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.009_bib34","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1245\/s10434-014-4223-3","article-title":"Is hepatic resection for large or multifocal intrahepatic cholangiocarcinoma justified? Results from a multi-institutional collaboration","volume":"22","author":"Spolverato","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.009_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znaf050","article-title":"Tumour burden predicts outcomes after curative resection of multifocal intrahepatic cholangiocarcinoma","volume":"112","author":"Kawashima","year":"2025","journal-title":"BJS"},{"issue":"9","key":"10.1016\/j.hoc.2026.05.009_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.110277","article-title":"Preoperative risk stratification for multifocal intrahepatic cholangiocarcinoma after liver resection: a multicenter analysis with CART model","volume":"51","author":"Fu","year":"2025","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.009_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jso.24633","article-title":"Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis","volume":"116","author":"Reames","year":"2017","journal-title":"J Surg Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2026.05.009_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.6004\/jnccn.2025.0042","article-title":"Biliary tract cancers, version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Benson","year":"2025","journal-title":"J Natl Compr Cancer Netw"},{"issue":"11","key":"10.1016\/j.hoc.2026.05.009_bib39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1089\/lap.2023.0193","article-title":"The role of staging laparoscopy for intrahepatic cholangiocarcinoma: a snapshot of the current literature","volume":"33","author":"Coletta","year":"2023","journal-title":"J Laparoendosc Adv Surg Tech"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.009_bib40","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00464-012-2519-6","article-title":"Staging laparoscopy in patients with hepatocellular carcinoma: is it useful?","volume":"27","author":"Hoekstra","year":"2013","journal-title":"Surg Endosc"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.009_bib41","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s11605-019-04275-0","article-title":"Effect of surgical Margin width on patterns of recurrence among patients undergoing R0 hepatectomy for T1 hepatocellular carcinoma: an international multi-institutional analysis","volume":"24","author":"Tsilimigras","year":"2020","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12957-023-02901-5","article-title":"The influence of resection margin width in patients with intrahepatic cholangiocarcinoma: a meta-analysis","volume":"21","author":"Dai","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.009_bib43","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1245\/s10434-022-12803-7","article-title":"Higher tumor burden status dictates the impact of surgical Margin status on overall survival in patients undergoing resection of intrahepatic cholangiocarcinoma","volume":"30","author":"Endo","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2026.05.009_bib44","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1245\/s10434-024-15868-8","article-title":"Tumor biology eventually prevails in the optimal treatment of perihilar cholangiocarcinoma","volume":"31","author":"Cheung","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2026.05.009_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186930","article-title":"Efficacy and safety of anatomic resection versus nonanatomic resection in patients with hepatocellular carcinoma: a systemic review and meta-analysis","volume":"12","author":"Tan","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12957-022-02770-4","article-title":"Oncological outcomes of anatomic versus non-anatomic resections for small hepatocellular carcinoma: systematic review and meta-analysis of propensity-score matched studies","volume":"20","author":"Dai","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.009_bib47","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1245\/s10434-025-17270-4","article-title":"Impact of tumor size on the survival benefit of anatomic versus non-anatomic resection for intrahepatic cholangiocarcinoma","volume":"32","author":"Kawashima","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.hoc.2026.05.009_bib48","doi-asserted-by":"crossref","first-page":"9170","DOI":"10.1245\/s10434-024-16121-y","article-title":"Anatomic versus non-anatomic liver resection for intrahepatic cholangiocarcinoma: a systematic review and patient-level meta-analysis","volume":"31","author":"Berardi","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.gassur.2025.102272","article-title":"Minimally invasive surgery for hepatocellular carcinoma: evolving trade-offs of patient selection and recurrence risk","volume":"30","author":"Akabane","year":"2025","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hoc.2026.05.009_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1021804","article-title":"Comparison of survival and post-operation outcomes for minimally invasive versus open hepatectomy in hepatocellular carcinoma: a systematic review and meta-analysis of case-matched studies","volume":"12","author":"Fu","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib51","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/SLA.0000000000005380","article-title":"A prospective study using propensity score matching to compare long-term survival outcomes after robotic-assisted, laparoscopic, or open liver resection for patients with BCLC stage 0-A hepatocellular carcinoma","volume":"277","author":"Zhu","year":"2023","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.009_bib52","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1007\/s00464-021-08842-y","article-title":"Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database","volume":"36","author":"Salehi","year":"2022","journal-title":"Surg Endosc"},{"issue":"10","key":"10.1016\/j.hoc.2026.05.009_bib53","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s11605-019-04404-9","article-title":"Is it time to consider laparoscopic hepatectomy for intrahepatic cholangiocarcinoma? A meta-analysis","volume":"24","author":"Wei","year":"2020","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"10.1016\/j.hoc.2026.05.009_bib54","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1007\/s00464-025-11900-4","article-title":"Minimally invasive liver surgery for perihilar and intrahepatic cholangiocarcinoma: systematic review and meta-analysis of comparative studies","volume":"39","author":"de Hondt","year":"2025","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11605-021-05039-5","article-title":"Extent of lymph node dissection for accurate staging in intrahepatic cholangiocarcinoma","volume":"26","author":"Kim","year":"2022","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.009_bib56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.hpb.2024.03.1163","article-title":"Is routine lymph node dissection recommended for liver resection of intrahepatic cholangiocarcinoma? A systematic review and meta-analysis","volume":"26","author":"Ishii","year":"2024","journal-title":"HPB (Oxford)"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.009_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.hpb.2023.11.007","article-title":"Value of lymph node dissection in intrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"26","author":"Yeow","year":"2024","journal-title":"HPB (Oxford)"},{"issue":"12","key":"10.1016\/j.hoc.2026.05.009_bib58","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1007\/s11605-023-05696-8","article-title":"Lymph node dissection in intrahepatic cholangiocarcinoma: a critical and updated review of the literature","volume":"27","author":"Llu\u00eds","year":"2023","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.009_bib59","first-page":"521","article-title":"Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report","volume":"107","author":"Makuuchi","year":"1990","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.009_bib60","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.7150\/jca.50371","article-title":"Preoperative portal vein embolization for liver resection: an updated meta-analysis","volume":"12","author":"Huang","year":"2021","journal-title":"J Cancer"},{"issue":"11","key":"10.1016\/j.hoc.2026.05.009_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11912-021-01075-1","article-title":"Systematic reviews and meta-analyses of portal vein embolization, associated liver partition and portal vein ligation, and radiation lobectomy outcomes in hepatocellular carcinoma patients","volume":"23","author":"Charalel","year":"2021","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.009_bib62","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jhep.2013.06.015","article-title":"Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection","volume":"59","author":"Vouche","year":"2013","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jvir.2024.09.025","article-title":"Liver vein deprivation versus portal vein embolization: retrospective review of safety and effectiveness","volume":"36","author":"Gadani","year":"2025","journal-title":"J Vasc Intervent Radiol"},{"issue":"11","key":"10.1016\/j.hoc.2026.05.009_bib64","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.hpb.2024.07.409","article-title":"Comparison of liver venous deprivation with portal vein embolization alone in patients undergoing major liver resection: a systematic review and meta-analysis","volume":"26","author":"Yang","year":"2024","journal-title":"HPB (Oxford)"},{"issue":"13","key":"10.1016\/j.hoc.2026.05.009_bib65","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/bjs.10290","article-title":"Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy","volume":"103","author":"Eshmuminov","year":"2016","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.009_bib66","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijsu.2014.03.009","article-title":"Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery","volume":"12","author":"Zhang","year":"2014","journal-title":"Int J Surg"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.009_bib67","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1245\/s10434-020-09478-3","article-title":"Neoadjuvant chemotherapy for intrahepatic cholangiocarcinoma: a propensity score survival analysis supporting use in patients with high-risk disease","volume":"28","author":"Utuama","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2026.05.009_bib68","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1245\/s10434-020-09536-w","article-title":"Time to rethink upfront surgery for resectable intrahepatic cholangiocarcinoma? Implications from the neoadjuvant experience","volume":"28","author":"Mason","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.009_bib69","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ejso.2019.03.023","article-title":"Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: a propensity score matched analysis","volume":"45","author":"Yadav","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib70","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12885-020-6610-4","volume":"20","author":"Goetze","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib71","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12885-024-12225-6","article-title":"A phase II\/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study","volume":"24","author":"Niger","year":"2024","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.009_bib72","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"issue":"10","key":"10.1016\/j.hoc.2026.05.009_bib73","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1245\/s10434-025-18046-6","article-title":"Real-world single-center experience with neoadjuvant gemcitabine, cisplatin, and durvalumab in borderline resectable cholangiocarcinoma","volume":"32","author":"Dong","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.009_bib74","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.surg.2023.04.043","article-title":"Adjuvant hepatic artery infusion pump chemotherapy for resected colorectal cancer liver metastases","volume":"174","author":"Standring","year":"2023","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.hoc.2026.05.009_bib75","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1245\/s10434-025-18222-8","article-title":"The landmark series: hepatic arterial infusion pump chemotherapy for colorectal liver metastases and intrahepatic cholangiocarcinoma","volume":"32","author":"Outmani","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.009_bib76","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaoncol.2019.3718","article-title":"Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial","volume":"6","author":"Cercek","year":"2020","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.009_bib77","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jso.23781","article-title":"Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma","volume":"111","author":"Boehm","year":"2015","journal-title":"J Surg Oncol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858826000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858826000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:29:46Z","timestamp":1784579386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858826000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0889858826000493"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2026.05.009","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical Considerations for Primary Liver Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2026.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}